1. EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases
   Sarah Urnauer et al, 2017, Oncotarget CrossRef
2. An Overview of Promising Biomarkers in Cancer Screening and Detection
   Saba Hasan, 2020, Current Cancer Drug Targets CrossRef
3. Role of WT1, B-cell lymphoma 2, Ki-67 (Mib1), and Her2/Neu as diagnostic and prognostic immunomarkers in ovarian serous and endometroid carcinoma
   Santosh Kumar Mondal et al, 2021, Journal of Cancer Research and Therapeutics CrossRef
4. EGFR as a prognostic biomarker and therapeutic target in ovarian cancer: evaluation of patient cohort and literature review
   Christine Mehner et al, 2017, Genes & Cancer CrossRef
5. Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel Concepts
   Gabriele Schubert-Fritschle et al, 2017, Frontiers in Oncology CrossRef
6. Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR)
   Sabine Heublein et al, 2013, Journal of Ovarian Research CrossRef